Skip to
  1. Homepage
  2. Rare diseases
  3. Search
Simple search

Simple search

*
(*) mandatory field





 

Other search option(s)

Charcot-Marie-Tooth disease type 4B2

Orpha number ORPHA99956
Synonym(s) CMT4B2
Prevalence Unknown
Inheritance
  • Autosomal recessive
Age of onset Childhood
ICD-10
  • G60.0
OMIM
UMLS
  • C1858278
MeSH
  • C535421
MedDRA -
SNOMED CT -

Summary

Charcot-Marie-Tooth disease, type 4B2 (CMT4B2) is a severe early-onset demyelinating CMT peripheral sensorimotor polyneuropathy.

It has been reported in families from Italy, Turkey, Tunisia, and Morocco.

CMT4B2 is clinically and pathologically very similar to CMT4B1 (see this term) with childhood-onset of muscle weakness, sensory loss, reduced nerve conduction velocities, characteristic myelin outfoldings and a severe disease course. However, in addition to the severe neuropathy, patients from some CMT4B2 families also develop early-onset glaucoma.

CMT4B2 is caused by mutations in the MTMR13/SBF2 gene encoding a protein involved in polyphosphoinositide signaling. Early-onset glaucoma is associated with specific nonsense SBF2 mutations and was not seen in CMT4B2 patients carrying a small in-frame SBF2 deletion.

CMT4B2 is transmitted in an autosomal recessive manner.

Expert reviewer(s)

  • Dr Carmen ESPINÓS
  • Pr Francesc PALAU

(*) Required fields.

Attention: Only comments seeking to improve the quality and accuracy of information on the Orphanet website are accepted. For all other comments, please send your remarks via contact us. Only comments written in English can be processed.


Captcha image

Detailed information

Anesthesia guidelines
  • EN (2014,pdf)
Clinical genetics review
  • EN (2014)
Get Acrobat Reader
The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.